These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
596 related articles for article (PubMed ID: 23583246)
1. Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics. Bartunek J; Behfar A; Dolatabadi D; Vanderheyden M; Ostojic M; Dens J; El Nakadi B; Banovic M; Beleslin B; Vrolix M; Legrand V; Vrints C; Vanoverschelde JL; Crespo-Diaz R; Homsy C; Tendera M; Waldman S; Wijns W; Terzic A J Am Coll Cardiol; 2013 Jun; 61(23):2329-38. PubMed ID: 23583246 [TBL] [Abstract][Full Text] [Related]
2. Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study. Teerlink JR; Metra M; Filippatos GS; Davison BA; Bartunek J; Terzic A; Gersh BJ; Povsic TJ; Henry TD; Alexandre B; Homsy C; Edwards C; Seron A; Wijns W; Cotter G; Eur J Heart Fail; 2017 Nov; 19(11):1520-1529. PubMed ID: 28560782 [TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of cardiopoietic stem cells in the treatment of post-infarction left-ventricular dysfunction - From cardioprotection to functional repair in a translational pig infarction model. Emmert MY; Wolint P; Jakab A; Sheehy SP; Pasqualini FS; Nguyen TDL; Hilbe M; Seifert B; Weber B; Brokopp CE; Macejovska D; Caliskan E; von Eckardstein A; Schwartlander R; Vogel V; Falk V; Parker KK; Gyöngyösi M; Hoerstrup SP Biomaterials; 2017 Apr; 122():48-62. PubMed ID: 28107664 [TBL] [Abstract][Full Text] [Related]
4. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial. Chung ES; Miller L; Patel AN; Anderson RD; Mendelsohn FO; Traverse J; Silver KH; Shin J; Ewald G; Farr MJ; Anwaruddin S; Plat F; Fisher SJ; AuWerter AT; Pastore JM; Aras R; Penn MS Eur Heart J; 2015 Sep; 36(33):2228-38. PubMed ID: 26056125 [TBL] [Abstract][Full Text] [Related]
18. Prospective evaluation of elastic restraint to lessen the effects of heart failure (PEERLESS-HF) trial. Costanzo MR; Ivanhoe RJ; Kao A; Anand IS; Bank A; Boehmer J; Demarco T; Hergert CM; Holcomb RG; Maybaum S; Sun B; Vassiliades TA; Rayburn BK; Abraham WT J Card Fail; 2012 Jun; 18(6):446-58. PubMed ID: 22633302 [TBL] [Abstract][Full Text] [Related]
19. Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study. Linde C; Gold MR; Abraham WT; St John Sutton M; Ghio S; Cerkvenik J; Daubert C; Eur Heart J; 2013 Sep; 34(33):2592-9. PubMed ID: 23641006 [TBL] [Abstract][Full Text] [Related]
20. Effect of intracoronary transplantation of autologous bone marrow-derived mononuclear cells on outcomes of patients with refractory chronic heart failure secondary to ischemic cardiomyopathy. Gao LR; Wang ZG; Zhu ZM; Fei YX; He S; Tian HT; Zhang NK; Chen Y; Xu HT; Yang Y Am J Cardiol; 2006 Sep; 98(5):597-602. PubMed ID: 16923443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]